Your browser doesn't support javascript.
May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines?
Giavina-Bianchi, Pedro; Kalil, Jorge.
  • Giavina-Bianchi P; Clinical Immunology and Allergy Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Kalil J; Clinical Immunology and Allergy Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
World Allergy Organ J ; 14(4): 100532, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1135595
ABSTRACT
Vaccination against coronavirus is essential to minimize the impact of the COVID-19 pandemic. Rare cases of anaphylaxis associated with the mRNA COVID-19 vaccines are being described, and the mechanisms involved in these reactions are poorly understood. A potential culprit agent of these vaccine-induced anaphylaxis events is polyethylene glycol, which has been reported as a cause of anaphylaxis. However, a cause-effect association has not been demonstrated, and the cases of anaphylaxis to mRNA COVID-19 vaccines should be further investigated. In this scenario, the recommendations are inaccurate and can lead to misinterpretation. At the moment, a more accurate recommendation would be the contraindication of mRNA COVID-19 vaccines in patients with immediate hypersensitivity reaction to polyethylene glycol or polysorbate. Patients with history of anaphylaxis to other or unknown causes should be referred to an allergist-immunologist for further orientation.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Journal: World Allergy Organ J Year: 2021 Document Type: Article Affiliation country: J.waojou.2021.100532

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Journal: World Allergy Organ J Year: 2021 Document Type: Article Affiliation country: J.waojou.2021.100532